Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,939 | 40,791 | 40,463 | 42,271 | 47,886 |
| Marketable Securities | 17,442 | 14,990 | 23 | 17 | 19 |
| Receivables | 806 | 891 | 127 | 256 | 213 |
| TOTAL | $56,164 | $59,157 | $42,260 | $43,844 | $49,984 |
| Non-Current Assets | |||||
| PPE Net | 2,497 | 2,566 | 2,157 | 2,255 | 2,149 |
| Intangibles | 42,372 | 42,372 | 42,372 | 42,372 | 57,212 |
| Other Non-Current Assets | 8,500 | 8,489 | 2,850 | 2,328 | 2,408 |
| TOTAL | $53,369 | $53,427 | $47,379 | $46,955 | $61,769 |
| Total Assets | $109,533 | $112,584 | $89,639 | $90,799 | $111,753 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,567 | 7,181 | 4,550 | 4,451 | 4,978 |
| Other current liabilities | 1,716 | 3,333 | 3,766 | 5,257 | N/A |
| TOTAL | $8,148 | $11,367 | $9,382 | $10,756 | $13,089 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 6,931 |
| Other Non-Current Liabilities | 35,624 | 45,399 | 46,657 | 19,759 | 7,078 |
| TOTAL | $48,690 | $57,871 | $59,461 | $32,931 | $21,009 |
| Total Liabilities | $56,838 | $69,238 | $68,843 | $43,687 | $34,098 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 249,298 | 249,088 | 230,328 | 228,356 | 228,356 |
| Common Shares | 529,656 | 515,467 | 494,175 | 490,551 | 489,313 |
| Retained earnings | -471,810 | -466,998 | -467,849 | -438,068 | -407,604 |
| Other shareholders' equity | -5,151 | -5,123 | -5,530 | -5,371 | -4,054 |
| TOTAL | $52,695 | $43,346 | $20,796 | $47,112 | $77,655 |
| Total Liabilities And Equity | $109,533 | $112,584 | $89,639 | $90,799 | $111,753 |